These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28654928)

  • 1. Risk Stratification of Patients with Crohn's Disease: A Retrospective Analysis of Clinical Decision Making and Its Impact on Long-Term Outcome.
    Mosli M; Sabbahi H; Alyousef H; Abdulhaq M; Hadadi A; Aljahdali E; Jawa H; Bazarah S; Qari Y
    Dig Dis; 2018; 36(1):49-55. PubMed ID: 28654928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?
    Mosli M; Alfaer S; Almalaki T; Albeshry A; Aljehani S; Alshmrani B; Habib Z; Jawa H; Qari Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):80-85. PubMed ID: 30199472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
    González-Lama Y; Suárez C; González-Partida I; Calvo M; Matallana V; de la Revilla J; Magaz M; Bernardo C; Agudo B; Ibarrola P; Relea L; Arévalo J; Vera MI; Abreu L
    J Crohns Colitis; 2016 Jan; 10(1):55-60. PubMed ID: 26520164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.
    Golovics PA; Lakatos L; Mandel MD; Lovasz BD; Vegh Z; Kurti Z; Szita I; Kiss LS; Pandur T; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(23):7272-80. PubMed ID: 26109815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
    Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
    BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres.
    Mandel MD; Balint A; Golovics PA; Vegh Z; Mohas A; Szilagyi B; Szabo A; Kurti Z; Kiss LS; Lovasz BD; Gecse KB; Farkas K; Molnar T; Lakatos PL
    Dig Liver Dis; 2014 Nov; 46(11):985-90. PubMed ID: 25156871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive review and update on Crohn's disease.
    Gajendran M; Loganathan P; Catinella AP; Hashash JG
    Dis Mon; 2018 Feb; 64(2):20-57. PubMed ID: 28826742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term outcome of anti-TNF alpha therapy in perianal Crohn's disease.
    Rayen J; Currie T; Gearry RB; Frizelle F; Eglinton T
    Tech Coloproctol; 2017 Feb; 21(2):119-124. PubMed ID: 28066859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical predictors of thiopurine-related adverse events in Crohn's disease.
    Moran GW; Dubeau MF; Kaplan GG; Yang H; Eksteen B; Ghosh S; Panaccione R
    World J Gastroenterol; 2015 Jul; 21(25):7795-804. PubMed ID: 26167079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region?
    Banerjee R; Pal P; Girish BG; Reddy DN
    Aliment Pharmacol Ther; 2018 May; 47(10):1367-1374. PubMed ID: 29572889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic Dilatation of Crohn's Anastomotic Strictures is Effective in the Long Term, and Escalation of Medical Therapy Improves Outcomes in the Biologic Era.
    Ding NS; Yip WM; Choi CH; Saunders B; Thomas-Gibson S; Arebi N; Humphries A; Hart A
    J Crohns Colitis; 2016 Oct; 10(10):1172-8. PubMed ID: 26971054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing Patient Management in Crohn's Disease in a Tertiary Referral Center: the Impact of Fast-Track MRI on Patient Management and Outcomes.
    Ilias A; Lovasz BD; Gonczi L; Kurti Z; Vegh Z; Sumegi LD; Golovics PA; Rudas G; Lakatos PL
    J Gastrointestin Liver Dis; 2018 Dec; 27(4):391-397. PubMed ID: 30574621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with perianal Crohn's fistulas experience delays in accessing anti-TNF therapy due to slow recognition, diagnosis and integration of specialist services: lessons learned from three referral centres.
    Lee MJ; Freer C; Adegbola S; Elkady S; Parkes M; Hart A; Fearnhead NS; Lobo AJ; Brown SR
    Colorectal Dis; 2018 Sep; 20(9):797-803. PubMed ID: 29569419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.
    Fiorino G; Morin M; Bonovas S; Bonifacio C; Spinelli A; Germain A; Laurent V; Zallot C; Peyrin-Biroulet L; Danese S
    J Crohns Colitis; 2017 Mar; 11(3):274-280. PubMed ID: 27799269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
    Safroneeva E; Vavricka SR; Fournier N; Pittet V; Peyrin-Biroulet L; Straumann A; Rogler G; Schoepfer AM;
    Aliment Pharmacol Ther; 2015 Oct; 42(8):977-89. PubMed ID: 26271358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors.
    Oh EH; Oh K; Han M; Seo H; Chang K; Lee SH; Kim GU; Song EM; Seo M; Lee HS; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
    PLoS One; 2017; 12(5):e0177479. PubMed ID: 28542298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen.
    Latella G; Cocco A; Angelucci E; Viscido A; Bacci S; Necozione S; Caprilli R
    Dig Liver Dis; 2009 Apr; 41(4):269-76. PubMed ID: 18955023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.
    Kiss LS; Lovasz BD; Golovics PA; Vegh Z; Farkas K; Molnar T; Palatka K; Papp M; Mohas A; Szilagyi BK; Fekete SA; Mandel M; Lakatos PL
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):135-40. PubMed ID: 23799211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
    Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of granulomas in children with Crohn's disease.
    Rothschild B; Rinawi F; Herman Y; Nir O; Shamir R; Assa A
    Scand J Gastroenterol; 2017; 52(6-7):716-721. PubMed ID: 28346037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.